NCT01523392 - A Pharmacodynamic Study With Ticagrelor in African American Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Stable Coronary Artery Disease

Interventions

DRUG

Ticagrelor

Min - 90mg/Max - 180mg tablets (loading dose)

DRUG

Clopidogrel

75mg (once daily)/Max - 600mg tablets (loading dose)

Trial Locations (8)

Research Site, Newark

Research Site, Wilmington

Research Site, Washington D.C.

Research Site, Hollywood

Research Site, Jacksonville

Research Site, Atlanta

Research Site, Towson

Research Site, Beaumont